Clinical Benefits of Combining Different Visualization Modalities in Neurosurgery.
CONVIVO
KINEVO
YELLOW 560 nm
brain tumors
confocal endomicroscopy
fluorescein sodium
fluorescence-guided surgery
tumor segmentation
Journal
Frontiers in surgery
ISSN: 2296-875X
Titre abrégé: Front Surg
Pays: Switzerland
ID NLM: 101645127
Informations de publication
Date de publication:
2019
2019
Historique:
received:
29
12
2018
accepted:
04
09
2019
entrez:
22
10
2019
pubmed:
22
10
2019
medline:
22
10
2019
Statut:
epublish
Résumé
The prevailing philosophy in oncologic neurosurgery, has shifted from maximally invasive resection to the preservation of neurologic function. The foundation of safe surgery is the multifaceted visualization of the target region and the surrounding eloquent tissue. Recent advancements in pre-operative and intraoperative visualization modalities have changed the face of modern neurosurgery. Metabolic and functional data can be integrated into intraoperative guidance software, and fluorescent dyes under dedicated filters can potentially visualize patterns of blood flow and better define tumor borders or isolated tumor foci. High definition endoscopes enable the depiction of tiny vessels and tumor extension to the ventricles or skull base. Fluorescein sodium-based confocal endomicroscopy, which is under scientific evaluation, may further enhance the neurosurgical armamentarium. We aim to present our institutional workup of combining different neuroimaging modalities for surgical neuro-oncological procedures. This institutional algorithm (IA) was the basis of the recent publication by Haj et al. describing outcome and survival data of consecutive patients with high grade glioma (HGG) before and after the introduction of our Neuro-Oncology Center.
Identifiants
pubmed: 31632980
doi: 10.3389/fsurg.2019.00056
pmc: PMC6781653
doi:
Types de publication
Journal Article
Langues
eng
Pagination
56Informations de copyright
Copyright © 2019 Schebesch, Rosengarth, Brawanski, Proescholdt, Wendl, Höhne, Ott, Lamecker and Doenitz.
Références
Surg Neurol Int. 2016 Dec 12;7(Suppl 40):S995-S1003
pubmed: 28144472
J Neurosurg Sci. 2018 Dec;62(6):704-717
pubmed: 30160080
Brain Sci. 2017 Dec 25;8(1):null
pubmed: 29295569
Curr Opin Neurol. 2009 Dec;22(6):645-9
pubmed: 19738467
Acta Neurochir (Wien). 2017 Feb;159(2):363-367
pubmed: 28012127
Neurosurg Focus. 2016 Mar;40(3):E11
pubmed: 26926051
J Nucl Med. 2004 Aug;45(8):1293-8
pubmed: 15299051
Clin Neurol Neurosurg. 2017 Apr;155:36-39
pubmed: 28242559
J Nucl Med. 2013 Feb;54(2):229-35
pubmed: 23232275
World Neurosurg. 2017 Aug;104:239-247
pubmed: 28512039
J Neurosurg. 2018 Jul;129(1):1-9
pubmed: 28885120
Magn Reson Imaging. 2013 Oct;31(8):1426-38
pubmed: 23790354
Phys Med Biol. 2013 Jul 7;58(13):R97-129
pubmed: 23743802
J Neurooncol. 2018 Sep;139(3):757-765
pubmed: 30117022
Front Surg. 2016 Oct 17;3:55
pubmed: 27800481
Neurosurgery. 2018 May 1;82(5):719-727
pubmed: 28645214
World Neurosurg. 2017 Nov;107:966-973
pubmed: 28755915
Clin Neurol Neurosurg. 2016 Apr;143:39-45
pubmed: 26895208
J Neurosurg. 2016 Apr;124(4):977-88
pubmed: 26495941
Cancer Manag Res. 2018 Oct 12;10:4325-4331
pubmed: 30349366
J Digit Imaging. 2017 Aug;30(4):449-459
pubmed: 28577131
Clin Neurol Neurosurg. 2018 Sep;172:177-182
pubmed: 30032095
Clin Cancer Res. 2018 Jan 1;24(1):52-61
pubmed: 29018053
Acta Neurochir (Wien). 2013 Jun;155(6):951-7
pubmed: 23447053
Neuroinformatics. 2015 Apr;13(2):209-25
pubmed: 25433513
J Neurosci Methods. 2007 Jun 15;163(1):128-36
pubmed: 17386945
Front Oncol. 2018 Jul 03;8:240
pubmed: 30035099
J Neurosurg. 2011 Jul;115(1):3-8
pubmed: 21417701
Clin Neurol Neurosurg. 2015 Dec;139:125-8
pubmed: 26432995
Rev Neurol (Paris). 2011 Oct;167(10):648-54
pubmed: 21903234
Surg Neurol Int. 2010 Oct 30;1:70
pubmed: 21125008
Acta Neurochir (Wien). 2013 Apr;155(4):693-9
pubmed: 23430234
Neurosurg Focus. 2016 Mar;40(3):E8
pubmed: 26926066